Vital Research Sibu-Caps 30 caps (20 mg/cap)

Sibutramine

Sibutramine tablets are specifically designed to aid individuals battling obesity, promoting weight loss when combined with a low-calorie diet and regular exercise. Many users notice significant weight reductions within the initial six months of treatment using Sibutramine tablets.

Offered by Abbott Laboratories, Sibutramine comes in two prominent brand names: Meridia? for the U.S. market and Reductil? in Europe. Initially, when a pharmaceutical company launches a new drug, it does so under a patent that restricts sales to just that company. Generics emerge once the patent expires, providing a cost-effective alternative. A generic Sibutramine offers the same active ingredients and therapeutic effects as its branded counterparts, but at a reduced price.

Generics must match the original formulation in active ingredients, ensuring identical dosage, efficacy, strength, and intended usage. Until patent protection is lifted, generics remain unavailable, impacting market pricing dynamics when they do become accessible.

Dosage

10-20 mg/day – variations may occur.